Avinger Inc (USD)
AVGR
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.34 | 0.36
52-Wk Range- | -
Last Close0.35
Mkt Cap (m)29.21
Dividend yield-
ISINUS0537346043
Volume4,822,401.00
Exchange VenueNAS

Company Profile

Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease.

Key Information
Price/Earning-
Price/Book3.87
Price/Sales0.61
P/CF-
Rev Growth (3 year avg)-21.96
EPS Growth (3 year avg)-
Operating Margin % -212.01
Net Margin %-213.01
Return on Equity-281.63
Debt/Equity2.00

Documents

Prospectus
en 21/08/2020
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

https://www.avinger.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)11.2110.7119.219.937.929.13
Operating Income (m)-25.03-40.69-50.72-39.51-22.07-19.36
Net Income (m)-31.96-47.34-56.13-48.73-27.56-19.45
Basic EPS-1,298.72-1,752.00-1,356.00-747.40-33.40-3.18
Avg. Diluted Shares Outstanding (m)0.020.030.040.071.077.24
Balance Sheet
USD201420152016201720182019
Current Assets (m)18.9451.0648.7911.4521.6216.62
Non Current Assets (m)5.843.054.773.642.087.20
Total Assets (m)24.7854.1053.5615.0923.7023.83
Current Liabilities (m)8.887.4848.7750.4814.2012.79
Total Liabilities (m)------
Total Equity (m)-143.8715.594.24-35.699.466.90
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-21.80-40.88-53.07-34.48-18.47-17.26
Capital Expenditure (m)-0.12-0.58-0.97-0.05-0.03-0.09
Figures are quoted in USD unless stated otherwise
-
No change
$
0.35
Last Price